مشارکت در فعالیت های پژوهشی حیطه سرطان پستان در طول سال گذشته:
A Phase III, randomized, two-armed, patient-outcome assessor-data analyzer blinded, parallel active controlled non-Inferiority clinical trial study of AryoTrust™ (AryogenTrastuzumab) efficacy and safety in Human Epidermal Growth Factor Receptor 2–Positive breast cancer in comparison to Herceptin® (Genentech/Roche) control
A Phase III , randomized, two armed, parallel, double-blind, active controlled, equivalency clinical trial to determine the therapeutic efficacy and safety between Pertuzumab (produced by CinnaGen Co.) plus Trastuzumab, Carboplatin and Docetaxel compared
Tamoxifen in the Management of Breast Cancer: A Case Presented in Multidisciplinary Session With Clinical Discussion and Decision-Making
Treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer: A report from cancer institute of Iran
Trastuzumab-induced cardiomyopathy evaluation by combined echocardiography and biomarkers in patients with breast cancer
Assessment of carvedilol therapy in prevention of heart failure in HER2 positive breast cancer patients receiving trastuzumab